Copy number alterations that predict metastatic capability of human breast cancer
A technology for human breast cancer and prognosis, applied in the direction of biochemical equipment and methods, microbial measurement/testing, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0016] Specific DNA copy number alterations (CNAs), such as deletions and amplifications, are major genomic changes that contribute to carcinogenesis and tumor progression through decreased apoptosis, uncontrolled proliferation and increased motility and angiogenesis. Since a large proportion of genomic aberrations are not related to cancer biology but are simply caused by random neutral events, it is a challenge to identify those causative gene CNAs responsible for the regulation of gene expression ultimately leading to malignant transformation and progression . Fluorescence in situ hybridization and comparative genomic hybridization (CGH) have both revealed chromosomal regions displaying CNAs in breast tumors. In a recent study including 51 breast tumors, high-resolution SNPs were used in combination with gene expression profiling to refine breast cancer amplicon boundaries and narrow the list of potential driver genes. However, only a few studies have examined the prognost...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com